Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara J Kamicker

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 29, 2011
Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis mediaAdriano Arguedas, Carolina Soley, Barbara J Kamicker, et al.
Methods in Molecular Medicine|April 26, 2008
Bacterial efflux pump inhibitorsBarbara J Kamicker, Michael T Sweeney, Frank Kaczmarek, et al.
Vaccine|January 24, 2018
Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccineJosé Barrera, Christopher Schutta, Melia Pisano, et al.
BMC Veterinary Research|August 31, 2018
Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission modelJohn G Neilan, Christopher Schutta, José Barrera, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Synthesis, stereochemical assignment and biological activity of a novel series of C-4" modified aza-macrolidesBrian S Bronk, Michael A Letavic, Camilla D Bertsche, et al.
Vaccine|December 29, 2015
Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challengeChristopher Schutta, José Barrera, Melia Pisano, et al.
Vaccine|October 18, 2018
Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccineJosé Barrera, David A Brake, Christopher Schutta, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Azalide 3,6-ketals: antibacterial activity and structure-activity relationships of aryl and hetero aryl substituted analoguesSubas M Sakya, Peter Bertinato, Bryan Pratt, et al.
Vaccine|November 14, 2019
Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattleRobin Steigerwald, David A Brake, José Barrera, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|June 20, 2018
An improved, rapid competitive ELISA using a novel conserved 3B epitope for the detection of serum antibodies to foot-and-mouth disease virusChungwon J Chung, Alfonso Clavijo, Mangkey A Bounpheng, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 29, 2011
Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis mediaAdriano Arguedas, Carolina Soley, Barbara J Kamicker, et al.
Methods in Molecular Medicine|April 26, 2008
Bacterial efflux pump inhibitorsBarbara J Kamicker, Michael T Sweeney, Frank Kaczmarek, et al.
Vaccine|January 24, 2018
Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccineJosé Barrera, Christopher Schutta, Melia Pisano, et al.
BMC Veterinary Research|August 31, 2018
Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission modelJohn G Neilan, Christopher Schutta, José Barrera, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Synthesis, stereochemical assignment and biological activity of a novel series of C-4" modified aza-macrolidesBrian S Bronk, Michael A Letavic, Camilla D Bertsche, et al.
Vaccine|December 29, 2015
Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challengeChristopher Schutta, José Barrera, Melia Pisano, et al.
Vaccine|October 18, 2018
Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccineJosé Barrera, David A Brake, Christopher Schutta, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Azalide 3,6-ketals: antibacterial activity and structure-activity relationships of aryl and hetero aryl substituted analoguesSubas M Sakya, Peter Bertinato, Bryan Pratt, et al.
Vaccine|November 14, 2019
Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattleRobin Steigerwald, David A Brake, José Barrera, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|June 20, 2018
An improved, rapid competitive ELISA using a novel conserved 3B epitope for the detection of serum antibodies to foot-and-mouth disease virusChungwon J Chung, Alfonso Clavijo, Mangkey A Bounpheng, et al.
Pageof 2